These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1138156)

  • 1. Dose-response study of the inhibiting effect of somatostatin on growth hormone and insulin secretion in normal subjects and acromegalic patients.
    Giustina G; Peracchi M; Reschini E; Panerai E; Pinto M
    Metabolism; 1975 Jul; 24(7):807-15. PubMed ID: 1138156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of somatostatin on plasma insulin and growth hormone levels in basal conditions and after glucagon in normal and acromegalic subjects.
    Massara F; Porzio G; Camanni F; Molinatti GM
    Acta Diabetol Lat; 1975; 12(3-4):219-31. PubMed ID: 1224905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of somatostatin on basal levels of plasma growth hormone and insulin in acromegalics: dose-response studies and attempted total growth hormone suppression.
    Christensen SE; Nerup J; Hansen AP; Lundbaek K
    J Clin Endocrinol Metab; 1976 May; 42(5):839-45. PubMed ID: 773950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE; Perfetti MG; Andreotti AC; Fattor B; Monti LD; Pozza G
    Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a single administration of somatostatin analogue (SMS 201-995) on GH, TSH and insulin secretion in patients with acromegaly.
    Horikawa R; Takano K; Hizuka N; Asakawa K; Shibasaki T; Masuda A; Shizume K
    Endocrinol Jpn; 1986 Dec; 33(6):743-9. PubMed ID: 2884093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of somatostatin on dibutyryl cyclic AMP-induced insulin and growth hormone release in human subjects.
    Peracchi M; Reschini E; Cantalamessa L; Catania A; Giustina G
    Metabolism; 1976 Mar; 25(3):321-8. PubMed ID: 175241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ingestion of glucose on GH and TSH secretion: evidence for stimulation of somatostatin release from the hypothalamus by acute hyperglycemia in normal man and its impairment in acromegalic patients.
    Shibasaki T; Masuda A; Hotta M; Yamauchi N; Hizuka N; Takano K; Demura H; Shizume K
    Life Sci; 1989; 44(6):431-8. PubMed ID: 2563893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of somatostatin on thyrotropin, prolactin, growth hormone and insulin responses to thyrotropin releasing hormone and arginine in healthy, hypothyroid and acromegalic subjects.
    Faure N; Dussault JH; Nadeau A; Szots F; Guyda H; Labrie F
    Can Med Assoc J; 1977 Sep; 117(5):478-81. PubMed ID: 409475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics.
    Trovati M; Massara F; Camanni F; Molinatti GM; Lorenzati R; Pagano GF
    J Endocrinol Invest; 1980; 3(2):189-92. PubMed ID: 6104680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on growth hormone secretion. VII. Effects of somatostatin on plasma GH, insulin, and glucagon in sheep.
    Bryce D; Yeh M; Funderburk C; Todd H; Hertelendy F
    Diabetes; 1975 Sep; 24(9):842-50. PubMed ID: 169176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patients.
    Peracchi M; Reschini E; Cantalamessa L; Giustina G; Cavagnini F; Pinto M; Bulgheroni P
    Metabolism; 1974 Nov; 23(11):1009-15. PubMed ID: 4418535
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients.
    Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM
    Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly.
    Dunn PJ; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):167-74. PubMed ID: 1269163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of plasma levels of growth hormone, glucagon and insulin in ducklings: roles of free fatty acids and somatostatin.
    Foltzer C; Strosser MT; Harvey S; Mialhe P
    J Endocrinol; 1985 Jul; 106(1):21-5. PubMed ID: 2862214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly.
    Plewe G; Beyer J; Krause U; Neufeld M; del Pozo E
    Lancet; 1984 Oct; 2(8406):782-4. PubMed ID: 6148524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose tolerance and plasma immunoreactive insulin levels in acromegalics before and after selective transsphenoidal surgery.
    Roelfsema F; Frölich M
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):531-7. PubMed ID: 3886210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of somatostatin-28 and somatostatin-14 on basal growth hormone release and pancreatic function in immature ducks (Anas platyrhynchos).
    Strosser MT; Harvey S; Foltzer C; Mialhe P
    Gen Comp Endocrinol; 1984 Nov; 56(2):265-70. PubMed ID: 6150878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
    Kelijman M; Williams TC; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CB-154 therapy on the glucose tolerance, IRI and GH response to glucose administration in acromegaly.
    Demura R; Yamaguchi H; Demura H; Shizume K
    Endocrinol Jpn; 1978 Aug; 25(4):355-9. PubMed ID: 710371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.